Hospital Parapl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hospital parapl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hospital Parapl Today - Breaking & Trending Today

Neuroplast successfully completes patient inclusion of Phase II clinical trial for Traumatic Spinal Cord Injury

Neuroplast, a Dutch clinical-stage biotech, focusing on cell-based treatments for neurodegenerative diseases, has successfully completed patient inclusion of its Phase II randomized placebo-controlled double-blinded clinical trial to evaluate the effect size of Neuro-Cells® for Traumatic Spinal Cord Injury (TSCI) . ....

Antonio Oliviero , Claus Andersen , Traumatic Spinal Cord Injury , Hospital Nacional De Parapl , Principal Investigators Antonio Oliviero , Hospital Parapl , Professor Fin Biering S , Phd Claus Andersen , Principal Investigator ,

Neuroplast successfully completes patient inclusion of Phase II clinical trial for Traumatic Spinal Cord Injury

16 patients have been enrolled in a multicenter international, randomized, placebo-controlled, double-blinded Phase II clinical trial Goal: to determine the. ....

United States , Noord Holland , Claus Andersen , Antonio Oliviero , Erik Wolters , Netherlands Enterprise Agency , Brightlands Agrifood Fund , Dutch Ministry Of Economic Affairs , Traumatic Spinal Cord Injury , Hospital Nacional De Parapl , Principal Investigators Antonio Oliviero , Hospital Parapl , Professor Fin Biering S , Phd Claus Andersen , Principal Investigator , Johannes De Munter , Lumana Invest , Brightlands Venture Partners , Netherlands Enterprise , Hospital De Parapl , Nacional De Parapl , Venture Partners , Chemelot Ventures , Dutch Ministry , Economic Affairs , Spring Lifesciences Communication ,

First patient in stem cell trial for treatment of Traumatic Spinal Cord Injury

Neuroplast has enrolled its first patient in a Phase II clinical trial to evaluate efficacy of its transformative Neuro-Cells® treatment that aims to ....

United States , Agencia Espa , Antonio Oliviero , Medicamentosy Productos Sanitarios , National Videnskabsetisk Komit , Danish Medicines Agency , Traumatic Spinal Cord Injury , Hospital Nacional De Parapl , Principal Investigators Antonio Oliviero , Hospital Parapl , Principal Investigator , Spinal Cord Injury , Spinal Cord , Productos Sanitarios , Danish Medicines , Johannes De Munter , Traumatic Brain Injury ,

Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells treatment for Traumatic Spinal Cord Injury

Neuro-Cells treatment aims to reduce irreversible damage to the central nervous system from secondary inflammation following traumaThe randomized, placebo-controlled, international multi-center ....

United States , Noord Holland , Kostenloser Wertpapierhandel , Erik Wolters , Prnewswire Neuroplast , Antonio Oliviero , Medicamentosy Productos Sanitarios , Brightlands Agrifood Fund , National Videnskabsetisk Komit , Netherlands Enterprise Agency , Danish Medicines Agency , Dutch Ministry Of Economic Affairs , Traumatic Spinal Cord Injury , Traumatic Brain Injury , Frontotemporal Dementia , Hospital Nacional De Parapl , Principal Investigators Antonio Oliviero , Hospital Parapl , Principal Investigator , Spinal Cord Injury , Spinal Cord , Agencia Espanola De Medicamentos , Productos Sanitarios , Danish Medicines , Johannes De Munter , Lumana Invest ,

Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells® treatment for Traumatic Spinal Cord Injury

Neuro-Cells® treatment aims to reduce irreversible damage to the central nervous system from secondary inflammation following trauma The randomized,. ....

United States , Noord Holland , Agencia Espa , Erik Wolters , Prnewswire Neuroplast , Antonio Oliviero , Medicamentosy Productos Sanitarios , Brightlands Agrifood Fund , National Videnskabsetisk Komit , Netherlands Enterprise Agency , Danish Medicines Agency , Dutch Ministry Of Economic Affairs , Traumatic Spinal Cord Injury , Traumatic Brain Injury , Frontotemporal Dementia , Hospital Nacional De Parapl , Principal Investigators Antonio Oliviero , Hospital Parapl , Principal Investigator , Spinal Cord Injury , Spinal Cord , Productos Sanitarios , Danish Medicines , Johannes De Munter , Lumana Invest , Brightlands Venture Partners ,